Genetic links between birth defects and childhood cancer

Integrating Epidemiologic and Genomic Data to Elucidate the Genetic Overlap Between Congenital Anomalies and Pediatric Cancer

NIH-funded research University of Tx Md Anderson Can Ctr · NIH-11182584

Looking for shared genes that might explain why some children born with birth defects have a higher chance of developing cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11182584 on NIH RePORTER

What this research studies

You will hear about work that combines large birth-defect and cancer registries with genetic data to find inherited gene changes shared between specific birth defects and childhood cancers. The team is expanding prior registry-linkage work across multiple states and adding germline genomic sequencing to identify novel cancer predisposition genes. They will examine both chromosomal conditions (like Down syndrome) and non-chromosomal birth defects to find patterns of risk. Most results come from analyzing existing registry records and genetic samples rather than new clinical treatments.

Who could benefit from this research

Good fit: Ideal candidates are children or young adults born with congenital anomalies (including chromosomal disorders or non-syndromic birth defects) who are in participating registries or have genetic samples available.

Not a fit: People without congenital anomalies or those not represented in the participating registries or without available genetic samples are unlikely to directly benefit from this project.

Why it matters

Potential benefit: If successful, this could help identify children at higher cancer risk sooner and guide monitoring, genetic counseling, and personalized follow-up.

How similar studies have performed: Previous registry-linkage and genomic work from this team has already revealed new congenital anomaly–cancer links and identified a novel leukemia predisposition gene (USP9X), indicating the approach can yield discoveries.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.